Skip to content

Trace Element Repletion Following Severe Burn Injury

Trace Element Repletion Following Severe Burn Injury

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03204669
Enrollment
139
Registered
2017-07-02
Start date
1999-06-01
Completion date
2015-12-31
Last updated
2017-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn Injury, Critical Illness, Nutritional Deficiency, Trace Element Deficiency

Keywords

Copper, Selenium, Zinc, Continuous renal replacement therapy

Brief summary

Major burn patients are characterized by large exudative losses of Cu, Se and Zn. Trace element (TE) repletion has been shown to improve clinical outcome. The study aimed to check if our repletion protocols were achieving normalization of TE plasma concentrations of major burn patients and if the necessity for continuous renal replacement therapy (CRRT) might increase the needs.

Detailed description

Retrospective analysis of prospectively collected data in burn patients requiring intensive care (ICU) between 1999 and 2015. The cohort was divided into 4 groups according to the protocol changes. Period 1 (P1): 1999-2000, P2: 2001-2005, P3: 2006-2010, P4: 2011-2015. Changes consisted mainly in increasing TE repletion doses and duration. Demographic data, daily TE intakes and weekly plasma concentrations were retrieved for the first 21 ICU-days.

Interventions

OTHERTrace elements replacement

Sponsors

Centre Hospitalier Universitaire Vaudois
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to 86 Years
Healthy volunteers
No

Inclusion criteria

* Burn injury involving ≥20% body surface (TBSA) (i.e. the threshold for intravenous TE repletion prescription) * At least one TE plasma concentration during the ICU stay

Exclusion criteria

* Comfort care * Admission \>24h after burn injury

Design outcomes

Primary

MeasureTime frameDescription
Trace elements plasma concentration21 daysCopper, Selenium and Zinc plasma concentrations, measured by inductively coupled plasma mass spectrometry (ICP-MS). The recommendation was to check them on a weekly basis.

Secondary

MeasureTime frameDescription
Number of infectious complications21 daysInfectious complications retrieved from the discharge reports, based on microbiological findings and antibiotherapy introduction or rotation. Multiple positive cultures were considered only once when they were related to a unique infectious episode. Concomitant sites of infection, including primary bloodstream infections, were considered as separate episodes of infections. Episodes of infections due to several microorganisms were considered only once. Infections were defined according to the criteria of the Center for Disease Control (CDC), American Burn Association (ABA) and International sepsis forum.
Length of mechanical ventilationUp to 120 daysNumber of days on the ventilator by the time the patient is discharged from hospital.
Length of stayUp to 250 daysNumber of days spent in the ICU by the time the patient is discharged from hospital.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026